Combined use of angiogenesis inhibitor and taxane

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 215/48 (2006.01) A61K 31/337 (2006.01) A61K 31/47 (2006.01) A61P 35/00 (2006.01) A61P 43/00 (2006.01)

Patent

CA 2713930

The problems of the present invention are to find a pharmaceutical composition and a method for treating cancer that exhibit excellent anti-tumor effect. Excellent anti--tumor effect is achieved when 4-(3-chloro-4--(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6- quinolinecarboxamide, an analogous compound thereof, a pharmacologically acceptable salt thereof or a solvate thereof is used in combination with taxane.

L'objet est de découvrir une composition pharmaceutique présentant un excellent effet antitumoral et un procédé thérapeutique pour le cancer. Le 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophénoxy)-7-méthoxy-6-quinoléinecarboxamide, un composé analogue ou l'un de ses sels pharmacologiquement acceptables, ou un solvate du composé ou du composé analogue ou du sel pharmacologiquement acceptable peut présenter un excellent effet antitumoral lorsqu'il est utilisé en combinaison avec un taxane.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Combined use of angiogenesis inhibitor and taxane does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combined use of angiogenesis inhibitor and taxane, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combined use of angiogenesis inhibitor and taxane will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1553224

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.